The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Novo Nordisk's oral semaglutide gets EU approval for heart related treatment of type 2 diabet
Alembic Pharmaceuticals receives EIR for API - I and API - II facility located at Panelav
CIDSCON 2025 emphasized a multi-faceted approach to tackle AMR
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes